Literature DB >> 7940422

The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores.

S P Conway1, M N Pond, I Bowler, D L Smith, E J Simmonds, D N Joanes, G Hambleton, E J Hiller, D E Stableforth, P Weller.   

Abstract

BACKGROUND: Scoring systems for the chest radiograph in cystic fibrosis are used to compare patients and different treatment regimens, and to monitor respiratory disease in individual patients. The Northern chest radiograph score was designed to allow one person to assess the radiological features of lung involvement in cystic fibrosis in as simple, rapid and equally reproducible manner as the established Chrispin and Norman, and Brasfield scoring systems.
METHODS: Forty five chest radiographs were scored by 10 physicians with a special interest in cystic fibrosis according to the Brasfield and Northern methods, and by five pairs of physicians according to the Chrispin-Norman criteria. Three individuals and two pairs rescored the radiographs after an interval of 3-5 months. The Northern score was performed with and without a lateral view, using the original posteroanterior radiograph.
RESULTS: The Northern score showed a better agreement between observers for the ranking of the radiographs. It was equally well related to respiratory function tests, the Shwachman-Kulczycki score of overall clinical status, and in its discrimination between different radiographs as the other two scoring systems. The Northern score performed equally well with or without a lateral film.
CONCLUSIONS: The Northern system fulfils the requirements of a chest radiograph score more successfully than the Chrispin-Norman or Brasfield systems, and does not require a lateral film.

Entities:  

Mesh:

Year:  1994        PMID: 7940422      PMCID: PMC475170          DOI: 10.1136/thx.49.9.860

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  Pulmonary changes in cystic fibrosis of the pancreas. A radio-pathological study.

Authors:  C J HODSON; N E FRANCE
Journal:  Clin Radiol       Date:  1962-01       Impact factor: 2.350

2.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

3.  The systematic evaluation of the chest radiograph in cystic fibrosis.

Authors:  A R Chrispin; A P Norman
Journal:  Pediatr Radiol       Date:  1974

4.  A new prognostic score and clinical evaluation system for cystic fibrosis.

Authors:  L M Taussig; J Kattwinkel; W T Friedewald; P A Di Sant'Agnese
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

5.  The correlation of radiological changes with pulmonary function in cystic fibrosis.

Authors:  B J Reilly; E A Featherby; T R Weng; D N Crozier; A Duic; H Levison
Journal:  Radiology       Date:  1971-02       Impact factor: 11.105

6.  Evaluation of a prophylactic and therapeutic program for patients with cystic fibrosis.

Authors:  C F Doershuk; L W Matthews; A S Tucker; S Spector
Journal:  Pediatrics       Date:  1965-11       Impact factor: 7.124

7.  Simple tests of ventilatory capacity in children with cystic fibrosis. I. Clinical and radiological findings in 85 patients. II. Three-year follow-up on 50 patients.

Authors:  M B Mearns
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

8.  Cystic fibrosis in adolescents and adults.

Authors:  A R Penketh; A Wise; M B Mearns; M E Hodson; J C Batten
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

9.  The relationship between chest radiographic scores and respiratory function tests in children with cystic fibrosis.

Authors:  D J Matthew; J O Warner; A R Chrispin; A P Norman
Journal:  Pediatr Radiol       Date:  1977
  9 in total
  28 in total

1.  Is limited computed tomography the future for imaging the lungs of children with cystic fibrosis?

Authors:  S C Langton Hewer
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

2.  Calprotectin as a marker of inflammation in cystic fibrosis.

Authors:  B E Golden; P A Clohessy; G Russell; M K Fagerhol
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

3.  Annual review or continuous assessment?

Authors:  S B Carr; R Dinwiddie
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

4.  Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis.

Authors:  L S Miall; N T McGinley; K G Brownlee; S P Conway
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

5.  Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.

Authors:  S P Conway; M N Pond; A Watson; C Etherington; H L Robey; M H Goldman
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

6.  Enhanced drug metabolism in young children with cystic fibrosis.

Authors:  A C Parker; P Pritchard; T Preston; R L Smyth; I Choonara
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

7.  Chest radiology in cystic fibrosis: is scoring useful?

Authors:  D J Shale
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

8.  Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study.

Authors:  R Mahadeva; K Webb; R C Westerbeek; N R Carroll; M E Dodd; D Bilton; D A Lomas
Journal:  BMJ       Date:  1998-06-13

9.  Comparative evaluation of chest radiography, low-field MRI, the Shwachman-Kulczycki score and pulmonary function tests in patients with cystic fibrosis.

Authors:  Angela Anjorin; Helga Schmidt; Hans-Georg Posselt; Christina Smaczny; Hanns Ackermann; Michael Deimling; Thomas J Vogl; Nasreddin Abolmaali
Journal:  Eur Radiol       Date:  2008-02-15       Impact factor: 5.315

10.  Modelling the bacterial communities associated with cystic fibrosis lung infections.

Authors:  T Spasenovski; M P Carroll; A K Lilley; M S Payne; K D Bruce
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-23       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.